The arrival of personalized medicine, or tailoring treatments based on a patient’s biological characteristics, has been anticipated for some time. Fully personalized medicine is not a reality today but the potential can be realized through careful connection between diagnostics and treatments and can result in more effective treatments, fewer ineffective treatments and ultimately, reduced healthcare costs.
Listen to Byron Hewett, who has more than 20 years of experience in healthcare and life sciences (including extensive experience with diagnostics), describe how medical technology and pharmaceutical companies must collaborate during discovery to develop diagnostics with the drug that they are using rather than separately.
Submitted comment may not display automatically.
Are you sure you want to disconnect with account?